Read + Share
Amedeo Smart
Independent Medical Education
Tokgoz S, Boss M, Jansen TJ, Meijer R, et al. Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes. Diabetes 2024 Nov 19:db240463. doi: 10.2337/db24-0463.PMID: 39561332
Email
LinkedIn
Privacy Policy